Jia Jie Biomedical Co Ltd Cash Flow Conversion Efficiency
Jia Jie Biomedical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$12.96 Million ≈ $408.15K USD) by net assets (NT$1.70 Billion ≈ $53.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jia Jie Biomedical Co Ltd (2015–2025)
Cash flow conversion efficiency of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart illustrates how Jia Jie Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Jia Jie Biomedical Co Ltd stock price today for real-time trading data and today's change.
Jia Jie Biomedical Co Ltd Cash Flow Conversion Ratio Explained
Jia Jie Biomedical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jia Jie Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their cash flow conversion efficiency. Also see Jia Jie Biomedical Co Ltd (4109) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sinsin Pharmaceutical Co. Ltd
KQ:002800
|
0.066x |
|
RENALYTIX PLC LS-0025
F:2O9
|
5.414x |
|
East Asia Holdings Investment Limited
KQ:900110
|
0.017x |
|
Staatl. Mineralbrunnen AG
MU:SLB
|
N/A |
|
RFTech Co. Ltd
KQ:061040
|
-0.045x |
|
Dish TV India Limited
NSE:DISHTV
|
-0.029x |
|
TradeDoubler AB
ST:TRAD
|
0.041x |
|
Xos Inc
NASDAQ:XOS
|
-0.118x |
Annual Cash Flow Conversion Efficiency for Jia Jie Biomedical Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Jia Jie Biomedical Co Ltd from 2015 to 2025. Review 4109 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.71 Billion ≈ $54.00 Million |
NT$21.34 Million ≈ $672.42K |
0.012x | -61.83% |
| 2024-12-31 | NT$1.36 Billion ≈ $42.82 Million |
NT$44.35 Million ≈ $1.40 Million |
0.033x | +878.02% |
| 2023-12-31 | NT$1.07 Billion ≈ $33.72 Million |
NT$-4.49 Million ≈ $-141.40K |
-0.004x | +55.86% |
| 2022-12-31 | NT$923.96 Million ≈ $29.11 Million |
NT$-8.78 Million ≈ $-276.56K |
-0.010x | -303.12% |
| 2021-12-31 | NT$934.93 Million ≈ $29.46 Million |
NT$4.37 Million ≈ $137.77K |
0.005x | -84.33% |
| 2020-12-31 | NT$907.97 Million ≈ $28.61 Million |
NT$27.10 Million ≈ $853.80K |
0.030x | -16.07% |
| 2019-12-31 | NT$694.88 Million ≈ $21.89 Million |
NT$24.71 Million ≈ $778.56K |
0.036x | +293.94% |
| 2018-12-31 | NT$714.19 Million ≈ $22.50 Million |
NT$-13.10 Million ≈ $-412.60K |
-0.018x | +6.56% |
| 2017-12-31 | NT$699.60 Million ≈ $22.04 Million |
NT$-13.73 Million ≈ $-432.54K |
-0.020x | +75.32% |
| 2016-12-31 | NT$962.54 Million ≈ $30.33 Million |
NT$-76.54 Million ≈ $-2.41 Million |
-0.080x | -195.08% |
| 2015-12-31 | NT$983.23 Million ≈ $30.98 Million |
NT$82.22 Million ≈ $2.59 Million |
0.084x | -- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more